ABFL - ETF AI Analysis
Top Page
Fcf Us Quality Etf (ABFL)
Rating:73Outperform
Price Target:―
Positive Factors
Strong Overall Performance
The ETF has shown strong gains so far this year, indicating solid recent momentum.
High-Quality Top Holdings
Many of the largest positions, including major technology and health care names, have delivered strong year-to-date results that support the fund’s performance.
Broad Sector Mix
Holdings spread across technology, industrials, health care, energy, and consumer sectors help reduce the impact of weakness in any single industry.
Negative Factors
Moderate Expense Ratio
The fund’s fee is not especially low, which slightly reduces the net return investors keep over time.
Heavy U.S. Concentration
Almost all assets are invested in U.S. companies, offering little geographic diversification if the U.S. market struggles.
Tilt Toward Technology
A large share of the portfolio is in technology stocks, which can make the ETF more sensitive to swings in that sector.
ABFL vs. SPDR S&P 500 ETF (SPY)
AUM531.83M
RegionNorth America
Expense Ratio0.49%
Beta0.95
IssuerAbacus
Inception DateSep 27, 2016
Dividend Yield0.54%
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume13,677
30 Day Avg. Volume13,334
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
98.43Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering56
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
ABFL Summary
ABFL, the Fcf US Quality ETF, invests in a wide range of U.S. companies with a focus on financially strong businesses that generate steady cash flow. It doesn’t track a specific index, but follows a “quality” theme across the total U.S. market, from large to small companies. Top holdings include well-known names like Apple and Nvidia, along with major health care and industrial firms. Someone might invest in ABFL for broad diversification while tilting toward higher-quality companies. A key risk is that it is heavily invested in U.S. stocks, especially technology, so its value can go up and down with that part of the market.
How much will it cost me?The Fcf US Quality ETF (ABFL) has an expense ratio of 0.49%, meaning you’ll pay $4.90 per year for every $1,000 invested. This is slightly higher than average because it is actively managed, focusing on selecting quality stocks with strong financial health and sustainable cash flow.
What would affect this ETF?The ABFL ETF, with its strong focus on U.S. quality stocks and significant exposure to technology, could benefit from continued innovation and growth in the tech sector, as well as stable economic conditions that support consumer spending and healthcare advancements. However, it may face challenges from rising interest rates, which can negatively impact growth-oriented sectors like technology and consumer cyclical, or from regulatory changes targeting large-cap tech companies. Its diversified holdings help mitigate risks, but sector-specific volatility remains a key factor to watch.
ABFL Top 10 Holdings
ABFL is leaning hard into U.S. tech and healthcare, with a clear tilt toward quality growth names. Nvidia, Lam Research, and Arista Networks are the main engines right now, riding strong AI and data-center demand and giving the fund much of its recent lift. Apple, by contrast, looks like it’s catching its breath, softening the overall tech punch. On the healthcare side, Bristol-Myers and AbbVie are quietly rising and adding stability. With all holdings U.S.-based, this ETF is a focused bet on American innovation and cash-rich blue chips.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Apple | 5.43% | $28.87M | $4.67T | 33.49% | 79 Outperform | |
| Nvidia | 5.16% | $27.43M | $5.55T | 37.92% | 76 Outperform | |
| Broadcom | 3.37% | $17.91M | $1.70T | 6.87% | 76 Outperform | |
| Bristol-Myers Squibb | 2.98% | $15.86M | $136.49B | 41.75% | 78 Outperform | |
| Eli Lilly & Co | 2.96% | $15.75M | $1.08T | 58.05% | 72 Outperform | |
| AbbVie | 2.94% | $15.62M | $453.19B | 20.65% | 66 Neutral | |
| Mastercard | 2.69% | $14.31M | $507.39B | -0.86% | 75 Outperform | |
| Cheniere Energy Partners | 2.58% | $13.72M | $33.27B | 27.32% | 61 Neutral | |
| Arista Networks | 2.56% | $13.62M | $244.40B | 35.65% | 83 Outperform | |
| Lam Research | 2.54% | $13.49M | $384.97B | 198.83% | 77 Outperform |
ABFL Technical Analysis
Neutral
―
Price Trends
82.98
Negative
81.75
Positive
76.92
Positive
Market Momentum
-0.33
Positive
45.75
Neutral
30.59
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For ABFL, the sentiment is Neutral. The current price of undefined is equal to the 20-day moving average (MA) of 82.96, equal to the 50-day MA of 82.98, and equal to the 200-day MA of 76.92, indicating a neutral trend. The MACD of -0.33 indicates Positive momentum. The RSI at 45.75 is Neutral, neither overbought nor oversold. The STOCH value of 30.59 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for ABFL.
ABFL Peer Comparison
Comparison Results
Performance Comparison
ABFL
Fcf Us Quality Etf
82.05
11.11
15.66%
VFMF
Vanguard U.S. Multifactor ETF
―
―
―
BGDV
Bahl & Gaynor Dividend ETF
―
―
―
AVTM
Avantis Total Equity Markets ETF
―
―
―
ULTY
YieldMax Ultra Option Income Strategy ETF
―
―
―
SMRI
Bushido Capital US Equity ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents